Antibody Technologies Market Research Reports & Industry Analysis
Antibody Technologies Industry Research & Market Reports
-
Graft Versus Host Disease (GvHD) Treatment Market Forecast – Epidemiology & Pipeline Analysis 2022-2027
... 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyses leading companies and several ... Read More
-
Global Primary Immunodeficiency Therapeutics Market 2022-2026
... the forecast period. Our report on the primary immunodeficiency therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report ... Read More
-
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2023-2028 World Outlook for Biosimilar Monoclonal Antibodies (mAb)
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2023-2028 World Outlook for Antibody Drugs
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2023-2028 World Outlook for Antibody Drug Conjugates
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2023-2028 World Outlook for AntiCD20 Monoclonal Antibodies
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2023-2028 World Outlook for Antibody Services
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
Global Antinuclear Antibody Test Market - 2022-2029
... at a CAGR of XX % during the forecast period (2022-2029). The anti-nuclear antibody test (ANA) or FANA (fluorescent anti-nuclear antibody) is a blood test that detects the presence of auto-antibodies in the serum, which ... Read More
-
The 2023-2028 World Outlook for Antibodies
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
The 2023-2028 World Outlook for Antibody Library Technologies
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2023-2028 World Outlook for Antibody Production
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2023-2028 World Outlook for Antinuclear Antibody Testing
... or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to ... Read More
-
The 2023-2028 World Outlook for Antinuclear Antibody Test Assay Kits and Reagents
... reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the ... Read More
-
The 2023-2028 World Outlook for Anti-HA Antibodies
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2023-2028 World Outlook for Breast Cancer Monoclonal Antibodies (mAb)
... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More
-
The 2023-2028 World Outlook for Albumin Plasma Protein Therapeutics
... latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the ... Read More
-
The 2023-2028 World Outlook for Biologicals
... (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country ... Read More
-
The 2023-2028 World Outlook for Bioengineered Monoclonal Antibodies Protein Drugs
... for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks ... Read More
-
Global Antibody Partnering Terms and Agreements 2015-2022
... the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter Antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains ... Read More
-
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2015-2022
... entered into by the worlds leading healthcare companies. Trends in cancer monoclonal antibody partnering deals Most active companies in cancer monoclonal antibody partnering Disclosed headlines, upfronts, milestones and royalties by stage of development Cancer monoclonal ... Read More
-
2022 Global: Research Antibodies - Innovative Markets Forecast (2028) report
... through 2028. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2017 to 2028 using regression analysis ... Read More
-
Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer, Urothelial/Bladder Cancer), By Technology (Cleavable, Non-cleavable Linker, Linkerless), And Segment Forecasts, 2022 - 2030
... a new report by Grand View Research Inc. The presence of strong pipeline products and strategic initiatives undertaken by the key players are expected to drive the market growth during the forecast period. Key players ... Read More
-
Global Respiratory Syncytial Virus (RSV) Vaccine And Antibody Pipeline Market: Analysis By End User, By Type, By Region, Size and Trends with Impact of COVID-19 and forecast up to 2028
... virus, is a common respiratory virus that causes mild, cold-like symptoms in both the upper and lower respiratory tracts. RSV can be harmful, especially in infants and the elderly, even though most individuals recover in ... Read More
-
Global Biosimilars Market Size study, By Product (Monoclonal Antibodies, Insulin, Granulocyte Colony-Stimulating Factor, Erythropoietin, Recombinant Human Growth Hormone, Etanercept, Follitropin, Teriparatide, Interferons, Enoxaparin Sodium, Glucagon, Cal
... Diseases, Blood Disorders, Growth Hormone Deficiency, Infectious Diseases, Other Indications), and Regional Forecasts 2022-2028 Global Biosimilars Market is valued at approximately USD 15.60 Billion in 2021 and is anticipated to grow with a healthy growth ... Read More